Nonsense codons in human beta-globin mRNA result in the production of mRNA degradation products.
Open Access
- 1 March 1992
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 12 (3) , 1149-1161
- https://doi.org/10.1128/mcb.12.3.1149
Abstract
Human beta zero-thalassemic beta-globin genes harboring either a frameshift or a nonsense mutation that results in the premature termination of beta-globin mRNA translation have been previously introduced into the germ line of mice (S.-K. Lim, J.J. Mullins, C.-M. Chen, K. Gross, and L.E. Maquat, EMBO J. 8:2613-2619, 1989). Each transgene produces properly processed albeit abnormally unstable mRNA as well as several smaller RNAs in erythroid cells. These smaller RNAs are detected only in the cytoplasm and, relative to mRNA, are longer-lived and are missing sequences from either exon I or exons I and II. In this communication, we show by using genetics and S1 nuclease transcript mapping that the premature termination of beta-globin mRNA translation is mechanistically required for the abnormal RNA metabolism. We also provide evidence that generation of the smaller RNAs is a cytoplasmic process: the 5' ends of intron 1-containing pre-mRNAs were normal, the rates of removal of introns 1 and 2 were normal, and studies inhibiting RNA synthesis with actinomycin D demonstrated a precursor-product relationship between full-length mRNA and the smaller RNAs. In vivo, about 50% of the full-length species that undergo decay are degraded to the smaller RNAs and the rest are degraded to undetectable products. Exposure of erythroid cells that expressed a normal human beta-globin transgene to either cycloheximide or puromycin did not result in the generation of the smaller RNAs. Therefore, a drug-induced reduction in cellular protein synthesis does not reproduce this aspect of cytoplasmic mRNA metabolism. These data suggest that the premature termination of beta-globin mRNA translation in either exon I or exon II results in the cytoplasmic generation of discrete mRNA degradation products that are missing sequences from exon I or exons I and II. Since these degradation products appear to be the same for all nonsense codons tested, there is no correlation between the position of translation termination and the sites of nucleolytic cleavage.Keywords
This publication has 49 references indexed in Scilit:
- Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay.Genes & Development, 1991
- Endonucleolytic cleavage of a maternal homeo box mRNA in Xenopus oocytes.Genes & Development, 1990
- The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways.Genes & Development, 1989
- A monoclonal antibody against 2,2,7‐trimethylguanosine that reacts with intact, class U, small nuclear ribonucleoproteins as well as with 7‐methylguanosine‐capped RNAsEuropean Journal of Biochemistry, 1987
- Translation is required for regulation of histone mRNA degradationCell, 1987
- H4 histone messenger RNA decay in cell-free extracts initiates at or near the 3′ terminus and proceeds 3′ to 5′Journal of Molecular Biology, 1986
- Interference of nonsense mutations with eukaryotic messenger RNA stability.Proceedings of the National Academy of Sciences, 1979
- Regulation of protein synthesis in mammalian cellsJournal of Molecular Biology, 1970
- The puromycin reaction and its relation to protein synthesisJournal of Molecular Biology, 1964
- Release of soluble protein from reticulocyte ribosomesBiochimica et Biophysica Acta, 1961